Preliminary trial results demonstrated that Imfinzi plus chemo improved event-free survival in resectable early-stage gastric ...

Tislelizumab plus chemotherapy received FDA approval as a frontline therapy for individuals with unresectable or metastatic ...

Among patients with early-stage triple-negative breast cancer, a beneficial pathologic complete response rate was higher in ...

AstraZeneca's Imfinzi perioperative regimen improved event-free survival in gastric and GEJ cancer. The trial showed a strong ...

British royal family news divulges that Prince William and Princess Catherine, the Duke and Duchess of Wales are in a new era ...

MATTERHORN is the first global phase 3 trial to show improved event-free survival with an immunotherapy combo vs standard ...

The NHS should follow Denmark and offer chemotherapy at home, a leading MP has said. Sir Geoffrey Clifton-Brown, the Tory MP who chairs the public accounts committee, urged the health service to learn ...

Chronic chemotherapy-induced peripheral neuropathy is a substantial burden among people with cancer treated with chemotherapy ...

A recent study shows that breast cancer survivors who undergo chemotherapy face prolonged physical decline, including fatigue ...

Breast cancer survivors treated with chemotherapy tend to suffer a longer-lasting decline in their physical health, compared ...

The critical role of EZH2, an essential epigenetic regulator, in cancer progression and treatment is underscored in this new review article published in Genes & Diseases.

A common type of diabetes medication could help cancer patients make a better long-term recovery, according to new research ...